Streptococcus pneumoniae (NORTHEAST Data) | |||||||
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
penicillin | 71.2% n=1265 | 60.9% n=593 | 61.8% n=793 | 64.2% n=689 | 75.5% n=424 | 75.5% n=147 | |
amoxicillin/clavulanate | 86.8% n=91 | 81.3% n=16 | 82.4% n=34 | 100% n=24 | |||
ampicillin | 100% n=27 | ||||||
vancomycin | 100% n=1043 | 99.8% n=548 | 100% n=622 | 99.9% n=736 | 99.8% n=452 | 99.5% n=216 | |
cefuroxime | 82.2% n=135 | 78% n=82 | 75.4% n=114 | 75.5% n=98 | |||
cefotaxime | 94.8% n=154 | 88.5% n=157 | 92.4% n=131 | 91.3% n=161 | 92.6% n=68 | ||
ceftriaxone | 97.7% n=1097 | 96.5% n=538 | 96.4% n=646 | 96.1% n=623 | 96.3% n=465 | 96.5% n=171 | |
clindamycin | 77.2% n=136 | 75.2% n=121 | 73% n=141 | 86.9% n=84 | 81.6% n=114 | ||
erythromycin | 73.4% n=726 | 61% n=492 | 64.3% n=686 | 67.8% n=512 | 66.6% n=365 | 78.3% n=83 | |
azithromycin | 54.4% n=125 | 46.4% n=181 | 46% n=100 | 58.6% n=29 | 73% n=37 | ||
clarithromycin | 59% n=100 | 31.3% n=16 | |||||
ciprofloxacin | 96.8% n=31 | ||||||
ofloxacin | 92.7% n=41 | 97.9% n=48 | |||||
levofloxacin | 98.8% n=409 | 98.8% n=345 | 98.1% n=263 | 99.1% n=331 | 98.1% n=315 | 98.1% n=159 | |
gatifloxacin | 100% n=103 | 100% n=160 | 100% n=100 | ||||
moxifloxacin | 99.2% n=484 | 98% n=101 | 98.6% n=351 | 98.1% n=160 | 100% n=44 | ||
TMP/SMX | 76.7% n=206 | 75.6% n=315 | 72.8% n=276 | 79.2% n=355 | 82.1% n=156 | 85.2% n=81 | |
chloramphenicol | 92.5% n=120 | 90.5% n=137 | 95.9% n=246 | 97.9% n=194 | 100% n=24 | ||
Totals | 86.8% n=6235 | 81.4% n=3834 | 82.2% n=4485 | 85.7% n=4035 | 87.3% n=2480 | 90.4% n=894 |
This data is accurate as of: 11/22/2016 11:53:35 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: amoxicillin/clavulanate, ampicillin, ofloxacin, cefuroxime, clarithromycin, clindamycin, ciprofloxacin, cefotaxime, azithromycin, moxifloxacin, chloramphenicol, erythromycin, TMP/SMX.